Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
33.20B | 33.77B | 28.57B | 26.84B | 27.30B | 27.69B | Gross Profit |
4.13B | 4.31B | 3.77B | 3.37B | 4.27B | 4.75B | EBIT |
795.00M | 886.00M | 564.00M | 221.00M | 1.05B | 1.77B | EBITDA |
1.52B | 4.01B | 1.40B | 879.00M | 1.65B | 2.39B | Net Income Common Stockholders |
538.00M | 2.19B | 415.00M | 123.00M | 775.00M | 1.33B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.08B | 3.08B | 2.20B | 2.32B | 3.25B | 1.48B | Total Assets |
37.93B | 37.76B | 33.67B | 28.79B | 27.79B | 25.05B | Total Debt |
13.52B | 10.78B | 9.02B | 6.45B | 4.95B | 4.69B | Net Debt |
10.43B | 7.69B | 6.82B | 4.13B | 1.70B | 3.21B | Total Liabilities |
27.59B | 25.44B | 23.26B | 18.86B | 17.96B | 15.73B | Stockholders Equity |
10.34B | 12.31B | 10.41B | 9.93B | 9.83B | 9.31B |
Cash Flow | Free Cash Flow | ||||
0.00 | -4.03B | -2.51B | -2.21B | 2.32B | -1.01B | Operating Cash Flow |
0.00 | -2.33B | -1.09B | -1.16B | 3.15B | -137.00M | Investing Cash Flow |
0.00 | 1.70B | -1.46B | -1.10B | -1.08B | -878.00M | Financing Cash Flow |
0.00 | 1.51B | 2.42B | 1.33B | -287.00M | 912.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥9.87B | 11.59 | 4.82% | 5.27% | -26.39% | ||
82 Outperform | ¥8.38B | 5.03 | 0.26% | 15.97% | 3.62% | ||
79 Outperform | ¥4.25B | 8.01 | 3.38% | -9.83% | 33.02% | ||
71 Outperform | ¥8.99B | 5.25 | 0.32% | 21.36% | 55.82% | ||
69 Neutral | ¥8.27B | 3.78 | 2.79% | 18.22% | 428.48% | ||
66 Neutral | $4.50B | 12.26 | 5.40% | 3.65% | 4.17% | -12.02% | |
54 Neutral | ¥7.14B | 4,038.46 | ― | -0.40% | -98.14% |